Company Quick10K Filing
Retail Opportunity Investments
10-Q 2021-03-31 Filed 2021-04-28
10-K 2020-12-31 Filed 2021-02-24
10-Q 2020-09-30 Filed 2020-10-27
10-Q 2020-06-30 Filed 2020-07-30
10-Q 2020-03-31 Filed 2020-04-23
10-K 2019-12-31 Filed 2020-02-19
10-Q 2019-09-30 Filed 2019-10-29
10-Q 2019-06-30 Filed 2019-07-25
10-Q 2019-03-31 Filed 2019-04-25
10-K 2018-12-31 Filed 2019-02-20
10-Q 2018-09-30 Filed 2018-10-24
10-Q 2018-06-30 Filed 2018-07-26
10-Q 2018-03-31 Filed 2018-04-26
10-K 2017-12-31 Filed 2018-02-22
10-Q 2017-09-30 Filed 2017-10-25
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-23
10-Q 2016-09-30 Filed 2016-10-26
10-Q 2016-06-30 Filed 2016-07-28
10-Q 2016-03-31 Filed 2016-04-28
10-K 2015-12-31 Filed 2016-02-24
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-02-25
10-Q 2014-09-30 Filed 2014-10-30
10-Q 2014-06-30 Filed 2014-07-31
10-Q 2014-03-31 Filed 2014-05-01
10-K 2013-12-31 Filed 2014-02-25
10-Q 2013-09-30 Filed 2013-10-31
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-05-03
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-03
10-Q 2012-03-31 Filed 2012-05-04
10-Q 2011-09-30 Filed 2011-11-04
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-05
10-Q 2010-03-31 Filed 2010-05-06
10-K 2009-12-31 Filed 2010-03-12
8-K 2020-10-26
8-K 2020-07-29
8-K 2020-07-29
8-K 2020-06-17
8-K 2020-04-22
8-K 2020-04-22
8-K 2020-04-09
8-K 2020-02-20
8-K 2020-02-18
8-K 2019-12-20
8-K 2019-10-28
8-K 2019-07-24
8-K 2019-06-04
8-K 2019-04-29
8-K 2019-04-24
8-K 2019-04-24
8-K 2019-02-19
8-K 2018-10-23
8-K 2018-07-25
8-K 2018-05-01
8-K 2018-04-25
8-K 2018-04-25
8-K 2018-02-21
8-K 2017-11-30

Retail Opportunity Investments Financials

ROIC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash15834111023576108131013111287915181013191110121512571199
Accounts Receivable
Inventory
PP&E4405856036446967258659011,0321,2111,3151,3781,6151,6061,6981,7961,8111,9172,1622,2242,4032,4242,4942,5762,6542,6862,8492,8602,8692,8422,8312,8102,7992,768
Assets5006516947147718209519921,1271,3131,4391,5031,7671,7711,8521,9491,9562,0632,3112,3812,5672,5872,6632,7492,8262,8613,0393,0503,0503,0153,0032,9942,9692,933
Accounts Payable
Long-Term Debt596078781211131131121049191756262787171299299
Liabilities1112722442653163484843874695937347998318268899891,0061,0321,1461,2131,3701,2621,3471,4411,5301,5741,7101,7271,7411,6891,6951,7001,6941,648
Stockholders' Equity3893794504504544724676056587197056759049139639609511,0301,1311,1681,1971,3241,3161,3081,2961,2871,3301,3221,3091,3261,3081,2941,2751,285
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue11141717181921242627343637414245465051565959636667687374727475767372
Cost of Revenue
Gross Profit
R&D
SG&A223234433323333343334333433444454
Tax00
Net Income130143-02225436754587998111191012128161215820
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating73469641316416132313291432123621421640244025442244402249
Cash Investing-112-20-39-52-35-135-34-142-63-105-71-241-14-73-101-33-118-86-10-194-40-81-98-95-51-79-28-33146-820
Cash Financing974211463911132128519960225-76073148675-20176-96864631155-197-66-42-16-69